Sonoma Pharmaceuticals (SNOA) EBT (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly EBT came in at -$497000.0 in Q1 2026, up 5.87% year-on-year from -$469438.3 in Q1 2025, and up 47.63% quarter-over-quarter from -$949000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) EBT (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' EBT history runs 17 years deep, the most recent figure standing at -$497000.0 for Q1 2026.
- On a quarterly basis, EBT rose 5.87% year-over-year to -$497000.0 in Q1 2026; TTM through Mar 2026 was -$3.4 million, a 17.61% decrease from a year earlier, with the FY2026 full-year figure at -$3.4 million, down 17.61% from the prior year.
- EBT grew to -$497000.0 in Q1 2026 per SNOA's latest filing, from -$949000.0 in the prior quarter.
- Across five years, EBT topped out at -$463000.0 in Q3 2024 and bottomed at -$3.3 million in Q1 2022.
- The 5-year median for EBT is -$949000.0 (2025), against an average of -$1.2 million.
- Across the five-year window, EBT plunged 865.26% in 2022 and jumped 64.33% in 2024, its largest moves.
- Year by year, EBT stood at -$1.9 million in 2022, then jumped by 51.55% to -$923000.0 in 2023, then increased by 0.43% to -$919000.0 in 2024, then dropped by 3.26% to -$949000.0 in 2025, then surged by 47.63% to -$497000.0 in 2026.
- Per Business Quant, the three latest SNOA EBT figures stand at -$497000.0 (Q1 2026), -$949000.0 (Q4 2025), and -$731000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -497,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -497,000.00 |
| Dec 31, 2025 | -949,000.00 |
| Sep 30, 2025 | -731,000.00 |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | -528,000.00 |
| Dec 31, 2024 | -919,000.00 |
| Sep 30, 2024 | -463,000.00 |
| Jun 30, 2024 | -997,000.00 |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | -923,000.00 |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | -1.45 Mn |
| Mar 31, 2023 | -1.44 Mn |
| Dec 31, 2022 | -1.91 Mn |
| Sep 30, 2022 | -917,000.00 |
| Jun 30, 2022 | -922,000.00 |
| Mar 31, 2022 | -3.28 Mn |
| Dec 31, 2021 | -944,000.00 |
| Sep 30, 2021 | -95,000.00 |
| Jun 30, 2021 | -1.10 Mn |